Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    21135146 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Condition: Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
Intervention: Other: Tumor core biopsy for RNA isolation
2 Not yet recruiting Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M (BOOSTER)
Condition: Non Small Cell Lung Cancer Metastatic
Interventions: Drug: Osimertinib;   Drug: Bevacizumab

Study has passed its completion date and status has not been verified in more than two years.